Background: Both medication and surgery are effective treatments for severe gastro-oesophageal reflux disease (GORD). Postoperative risks have contributed to decreased use of antireflux surgery. The aim of this study was to assess short-term mortality following primary laparoscopic fundoplication.
Introduction
Gastro-oesophageal reflux disease (GORD) is a public health concern, affecting 10-20 per cent of all adults in Western populations, and the rate is increasing 1 . GORD is associated with limitations to quality of life, and high costs for patients, healthcare and society. There is also a risk of severe complications following GORD, including a risk of oesophageal adenocarcinoma, which is an increasingly common cancer, with a poor prognosis 1 -4 . A recent meta-analysis 5 found that weekly and daily reflux symptoms entailed a fivefold and sevenfold increased risk of developing oesophageal adenocarcinoma respectively.
The two most effective treatment options for severe GORD are continuous and long-term medication with proton pump inhibitors (PPIs), and antireflux surgery with laparoscopic fundoplication 2, 3 . In current practice, surgery is typically recommended only to patients with GORD who experience an inadequate response to PPIs or who object to long-term use of PPIs. The literature indicates that laparoscopic fundoplication may be superior to PPI treatment in terms of reflux symptoms, oesophageal acid exposure, overall and GORD-associated quality of life, prevention of oesophageal adenocarcinoma, and long-term cost-effectiveness 3, 6 . The risk of mortality and morbidity following antireflux surgery has contributed strongly to its considerably decreased use in the past decade 2, 7, 8 , although studies 2,7 -9 suggest that surgical therapy may be underutilized. The reported overall perioperative and 30-day mortality rate is 0⋅45 per cent 2, 7, 8, 10 , and severe complications occur in up to 4 per cent 2, 3, 11 , which is not negligible for a benign disorder. However, studies addressing mortality and morbidity following antireflux surgery are old, or limited single-or multiple-institution series at best. Only two population-based studies are available; one 7 assessed inpatient postoperative mortality and morbidity, and the other 10 assessed 30-day mortality. Yet, with current improvements in postoperative care, 90-day mortality might be a better assessment of postoperative mortality in upper gastrointestinal surgery 12 .
The aim of the present study was to assess 90-day mortality and morbidity after primary laparoscopic fundoplication for GORD in a recent and unselected nationwide cohort with complete follow-up of all participants.
Methods
This was a nationwide, Swedish population-based, cohort study investigating the absolute risk of mortality and reoperation for up to 90 days after primary laparoscopic fundoplication during the study period, from 1 January 1997 to 31 December 2013. In addition, the relative risks of reoperation and prolonged postoperative hospital stay were determined.
The study cohort consisted of all patients aged 18-65 years who underwent laparoscopic fundoplication for a recorded diagnosis of GORD in Sweden during the study interval. Data were collected from nationwide Swedish registries. The unique ten-digit personal identity number assigned to each resident in Sweden upon birth or immigration enabled linkages of individuals' data between registries. The indication for surgery, the surgical technique used, and the cause of death were validated by retrieval of medical records for patients who died within 90 days after surgery during the study period.
The study was approved by the Regional Ethical Review Board in Stockholm, Sweden (reference number 2014/234-31).
Data retrieval and definition of exposure
All eligible patients (those who underwent laparoscopic fundoplication for GORD during the study period) were identified from the Swedish Patient Registry. GORD was used as a criterion for inclusion to avoid including fundoplication for other indications. The vast majority of the excluded patients had a fundoplication in association with oesophagogastric myotomy, mainly for achalasia. The Patient Registry records in-hospital and outpatient care since 1964, and includes discharge diagnoses, Data needed to calculate the rates of laparoscopic fundoplication per 100 000 inhabitants aged 18-65 years in Sweden were derived from the Patient Registry and the Swedish Registry of the Total Population. The latter registry has had 100 per cent nationwide completeness since 1947 15 . Diagnoses of GORD were retrieved from the Patient Registry (using ICD versions 7-10): GORD, heartburn, hiatal hernia, oesophagitis and Barrett's oesophagus.
Outcomes
Date and causes of death were identified from the Swedish Causes of Death Registry. This registry contains information on all deceased Swedish residents since 1952, with a completeness of 99⋅2 per cent 16 . All data in this registry are coded according to the ICD system. Data on the secondary outcomes (postoperative reoperation and prolonged hospital stay) were retrieved Patients who died within 90 days of surgery were excluded from the analyses addressing reoperation. Prolonged hospital stay was defined as duration of stay of 4 days or more after laparoscopic fundoplication, as this exceeds the routine length of stay 2, 17 . Length of hospital stay was calculated from the admission and discharge dates in the Patient Registry. To include any in-hospital days following discharge spent at another ward or hospital, any subsequent in-hospital care following admission for up to 1 day after discharge from the surgical ward was also included.
Co-variables
The study co-variables were sex, age, co-morbidity, date of admission and length of hospital stay, all collected from the Patient Registry. Co-variables were chosen based on known cause-effect relationships for increased morbidity and mortality in the previous literature. The co-variables and the model were determined in the study protocol before data collection to ensure nominal coverage of the confidence intervals (c.i.).
Co-morbidity was defined using the Charlson co-morbidity score, a well validated composite variable for quantification of co-morbidity, which is based on specific diagnosis codes 18 -21 . Patients were categorized into three Charlson co-morbidity score groups (0, 1, or 2 or above), a categorization that distinguishes the groups in terms of risk of mortality 18 .
Statistical analysis
The analyses were conducted using the statistical software SAS ® version 9.3 (SAS Institute, Cary, North Carolina, USA) and R 22 . The absolute risk of death and reoperation following laparoscopic fundoplication were calculated. The low number of deaths prohibited further analyses of short-term mortality.
A multivariable logistic regression model was used to assess the odds ratio (OR) and 95 per cent c.i. of reoperation within 90 days of surgery, as well as the OR of prolonged length of hospital stay. Adjustments were made for the co-variables age (continuous variable), sex (male or female), year of surgery (continuous variable) and Charlson co-morbidity score (0, 1, or 2 or above). Model assumptions and goodness of fit were checked formally and graphically 23 . The residuals were plotted against fitted values to assess (lack of) fit graphically. A check was made for overly influential observations using a plot of Cook's distance versus leverage. Overdispersion was checked by fitting a quasi-binomial instead of a binomial.
In the analysis of hospital stay, a thin-plate regression spline was used to model the effect of year of surgery. The number of knots was checked using a simulation approach. Although the exact basis dimension of a thin-plate spline is not generally critical, a sufficiently small value ensures computational efficiency 24 . The simulation approach described and implemented in the mgcv package for R was used, as described previously 25 . Briefly, an estimate of the residual variance of near neighbours was calculated. Residuals were reshuffled a number of times to obtain the null distribution of the differencing variance estimator (that is, no pattern was present in the residuals given the chosen basis dimension). All tests were two-tailed and statistical significance was set at P < 0⋅050.
Results
In total, 8947 patients constituted the laparoscopic fundoplication study cohort; their median age at operation was 48 years, the majority were men (5306, 59⋅3 per cent) and median length of hospital stay was 2 days ( Table 1) . Some 488 patients (5⋅5 per cent) had a Charlson score of 1, and 63 (0⋅7 per cent) had a score of 2 or more. A total of 290 patients were excluded as a GORD-related diagnosis was not recorded, including eight with a Charlson score greater than 1. None of these patients died within 90 days of surgery.
The annual number of laparoscopic fundoplication procedures decreased from 832 in 1997 to 144 in 2013 (Fig. 1) , and the number of procedures performed annually per 100 000 population decreased from 15⋅3 in 1997 to 2⋅4 in 2013 (Fig. 2) . The proportion of women increased from 40⋅5 per cent in 1997 to 48⋅6 per cent in 2013. During the study interval, the proportion of patients with a Charlson co-morbidity score of 1 and of 2 or more increased more than twofold and threefold respectively (Fig. 3) . The distribution of age and length of hospital stay remained constant throughout the study period.
Mortality
Seven patients died within 90 days of surgery, of whom three died within 30 days, giving 90-and 30-day all-cause mortality rates of 0⋅08 and 0⋅03 per cent respectively ( Table 1) . One patient (0⋅01 per cent) died from a direct surgery-related complication, acute respiratory distress syndrome, 19 days after operation; this was the only in-hospital death. Causes of the other six deaths were heart failure (2 patients), suicide (2), diabetic ketoacidosis (1) and accidental poisoning (1).
The indications for surgery and surgical technique used in all patients who died within 90 days were validated through medical records, and found to be accurate in all cases. The number of all-cause deaths was no greater than one in any of the 17 years studied (Fig. 1) . None of the deceased patients underwent reoperation. Compared with the other patients, those who died within 90 days of fundoplication had a longer median hospital stay (11 versus 2 days) and more co-morbidities with a Charlson score of 1 (29 versus 5⋅5 per cent respectively) and 2 or more (14 versus 0⋅7 per cent), whereas the distribution of sex and age was similar ( Table 1) .
Reoperation
The reoperation rate was 0⋅4 per cent (39 of 8947) within 90 days of laparoscopic fundoplication, and also 0⋅4 per cent (38 patients) within 30 days of surgery. In 1997, three reoperations were conducted, reaching an annual maximum of six in 2000, and with no more than one per year from 2008 onwards (Fig. 1) . The distribution of age, sex and co-morbidity was similar for patients in the 90-day reoperation group and the other study participants, whereas median length of hospital stay was greater in the reoperation group (6 versus 2 days) ( Table 1 ). There were no statistically significant associations between risk of reoperation and age, sex, year of surgery or co-morbidity ( Table 2) .
Prolonged hospital stay
Co-morbidity, female sex and higher age were associated with an increased risk of prolonged hospital stay ( Table 2 ). The risk of prolonged hospital stay was characterized by a complex pattern over time, descending from increased to decreased risk in the early to intermediate years of the 
Values in parentheses are 95 per cent confidence intervals. *Adjusted for sex, co-morbidity score, year of surgery and age at surgery. †Adjusted by spline (approximate significance of the smooth terms: P < 2 × 10 −16 ). n.a., Not applicable. 4 Odds ratios (ORs) with 95 per cent confidence intervals for prolonged hospital stay after laparoscopic fundoplication in patients with gastro-oesophageal reflux disease, adjusted for sex, co-morbidity and age at operation, 1997-2013 study, followed by a slight surge during the most recent 6 years (Fig. 4) . Overall, the risk declined over the study period, especially from the start of the study to 2005; after 2005 there was a slight increase.
Discussion
This nationwide study found very low all-cause and procedure-related mortality rates and reoperation rate following laparoscopic fundoplication for GORD in an unselected patient cohort. The increasing proportion of surgical patients with co-morbidity over time did not translate into an increase in mortality, reoperation or hospital stay. Methodological strengths of the study are the nationwide coverage and population-based design -including virtually all patients with GORD who underwent laparoscopic fundoplication in Sweden in 1997-2013 -which minimizes selection bias, facilitates generalizability, and provides a large sample size. Moreover, the complete and well maintained nationwide registries available in Sweden enabled complete follow-up of all patients, thus avoiding loss to follow-up.
Among potential weaknesses of the study is a risk of clinical selection of relatively healthy patients for surgery, yet often with particularly severe GORD. However, the surgical cohort reflects routine clinical practice and should have only a limited effect on the generalizability of the results. Moreover, the increasing presence of co-morbidity over time did not increase the risk of unfavourable short-term outcomes. As laparoscopic fundoplication can be performed for indications other than GORD, a diagnosis of GORD was required for inclusion. Although this improves the validity of the study, it also introduces a risk of missing eligible individuals who had GORD, but did not have this diagnosis recorded. However, this error should be limited because discharge diagnoses need to be recorded in the hospital discharge notes, which are transferred to the Swedish Patient Registry. Although adjustments for several potential confounding factors were made, information on some other potential confounders was not available, including tobacco smoking, which can increase the risk of postoperative complications. However, long-term smoking was indirectly adjusted for through adjustment for the Charlson co-morbidity score, which included chronic obstructive pulmonary disorder, a proxy diagnosis for tobacco smoking. Moreover, it is unlikely that information on tobacco smoking would change any of the main results. Finally, owing to the partial lack of data regarding exact date of surgery, the date of admission was used as a proxy. This assumption could have resulted in slightly imprecise postoperative follow-up dates.
A Cochrane systematic review 8 including four randomized clinical trials, all conducted in 1997-2004 (including a total of 519 patients with GORD), comparing laparoscopic fundoplication and PPI treatment reported no inpatient deaths (all trials), a 90-day reoperation rate of 3⋅7 per cent (4 patients; 1 trial) and no reoperations within 1 year (2 trials). Furthermore, an inpatient mortality rate of 0⋅13 per cent was calculated by the present authors based on data from a large cohort study in the USA 7 , and a population-based cohort study from Denmark 10 found a 30-day mortality rate of 0⋅45 per cent, both substantially higher than the 0⋅01 per cent found in the present study. It was not possible to calculate mortality within 30 or 90 days of surgery in the cohort study from the USA 7 , but the inpatient complication rate for each year studied showed a higher peak (8⋅1 versus 0⋅7 per cent in the present study) and trough (6⋅3 versus 0 per cent respectively). The higher inpatient mortality rate in the US study may be explained by the inclusion of patients of older age and with greater co-morbidity. Another cohort study from the USA 2 , which evaluated mortality in patients aged less than 70 years, showed a 30-day mortality rate of 0⋅05 per cent, which is more comparable to that in the present study (0⋅03 per cent). However, that study reported a higher complication rate (1⋅8 per cent) 2 . Finally, an older Finnish nationwide cohort study 11 revealed a 30-day mortality rate of 0⋅04 per cent, similar to that in the present study. However, the Finnish study did not assess surgery-related or 90-day mortality.
The increased risk of prolonged hospital stay with higher age and co-morbidity in this study could be explained by the greater disposition to postoperative complications and slower recovery in older patients compared with younger and fitter patients. Speculatively, a higher proportion of women with obesity and increased length of surgery could explain the higher risk of prolonged hospital stay found in female patients, as these factors correlate with extended hospital stay in other types of upper gastrointestinal surgery 26 .
A decreased use of fundoplication with calendar time has also been reported in the USA, where the use of antireflux surgery declined from 15⋅7 to 5⋅3 operations per 100 000 inhabitants between 1999 and 2010 7, 27 . This decline could be attributed to the increased use of PPIs since the early 2000s, an easily accessible drug proven to be effective in reflux control and with a well documented and safe profile 3, 28 . In addition, the potential risks of mortality and morbidity associated with antireflux surgery appear to have led general practitioners, gastroenterologists and possibly also surgeons predominantly to favour PPIs over surgery for treatment of GORD. Yet, both treatment options can effectively counteract GORD and improve quality of life, although surgery appears to be slightly superior in these respects 3 . Recurrence of GORD is similarly common following both treatments 3 , although surgery might be more effective in preventing oesophageal adenocarcinoma than PPI use 6 . Surgery might seem to be more costly in the short term, but is perhaps more cost-effective in the longer term 3 . In addition, concerns have arisen regarding an increased risk of osteoporosis, bone fractures and Clostridium difficile-associated diarrhoea following long-term treatment with PPIs 3 .
This study has demonstrated that laparoscopic fundoplication offers a safe alternative to PPI therapy for severe GORD, with a risk profile similar to that of other common laparoscopic procedures for benign diagnoses in a short-term setting (appendicectomy and cholecystectomy) 2 . The low risk might, at least partly, be due to the increased specialization of surgeons involved in minimally invasive upper gastrointestinal surgery. The slight superiority of laparoscopic fundoplication, along with its safety profile, and the increasingly recognized complications of long-term PPI use, argue for the adoption of a decreased threshold for recommending laparoscopic fundoplication in patients with severe GORD, particularly in fit patients aged less than 65 years.
